Issue 1, 2021
From the journal:

RSC Medicinal Chemistry

Retraction: MicroRNA-451 blockade promotes osteoblastic differentiation and skeletal anabolic effects by promoting YWHAZ-mediated RUNX2 protein stabilization

Katie Lima  

a Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, UK
E-mail: medchem-rsc@rsc.org

Abstract

Retraction of ‘MicroRNA-451 blockade promotes osteoblastic differentiation and skeletal anabolic effects by promoting YWHAZ-mediated RUNX2 protein stabilization’ by Jieen Pan et al., Med. Chem. Commun., 2018, 9, 1359–1368, DOI: 10.1039/C8MD00187A.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D1MD90001C
Article type
Retraction
Submitted
19 Jan 2021
Accepted
19 Jan 2021
First published
26 Jan 2021
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2021,12, 144-144

Permissions

Request permissions

Retraction: MicroRNA-451 blockade promotes osteoblastic differentiation and skeletal anabolic effects by promoting YWHAZ-mediated RUNX2 protein stabilization

K. Lim, RSC Med. Chem., 2021, 12, 144 DOI: 10.1039/D1MD90001C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements